Stoke Therapeutics Inc
F:0GT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Stoke Therapeutics Inc
F:0GT
|
US |
|
E
|
Electric Power Development Co Ltd
XMUN:FJG
|
JP |
|
R
|
Raunaq Epc International Ltd
BSE:537840
|
IN |
|
D
|
Deutsche Pfandbriefbank AG
DUS:PBB
|
DE |
|
C
|
Cizzle Brands Corp
OTC:CZZLF
|
CA |
|
T
|
Tower Resources Ltd
XTSX:TWR
|
CA |
|
W
|
Winner Nusantara Jaya Tbk PT
IDX:WINR
|
ID |
|
Taseko Mines Ltd
TSX:TKO
|
CA |
|
M
|
Metropolis Capital Holdings Ltd
HKEX:8621
|
CN |
|
H
|
Hana 32 Special Purpose Acquisition Co
KOSDAQ:475240
|
KR |
|
R
|
Rockwell Land Corp
XPHS:ROCK
|
PH |
|
M
|
Marudai Food Co Ltd
F:MFL2
|
JP |
|
K
|
KGA Co Ltd
KOSDAQ:455180
|
KR |
|
Want Want China Holdings Ltd
OTC:WWNTF
|
CN |
|
F
|
FNB Corp
F:FN2
|
US |
Bankruptcy Probability
Stoke Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Stoke Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Stoke Therapeutics Inc
NASDAQ:STOK
|
2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Stoke Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Stoke Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
